51˶

COVID's Silver Lining; 'I Could Kill Someone'; Measles or MMR Detection?

— Health news and commentary from around the Web gathered by 51˶ staff

MedpageToday
Morning Break over illustration of a syringe, Covid virus, and DNA helix over a photo of green vegetation.

Note that some links may require registration or subscription.

The COVID-19 pandemic has a : a rare opportunity to watch our immune system develop defenses against a novel pathogen in real time. (STAT)

Mpox cases in the U.S. are currently as they were this time last year, CDC data show. (CNN)

Pharmaceutical firm WuXi AppTec allegedly with Chinese authorities without consent, according to intelligence officials. (Reuters)

Two-thirds of U.S. babies with sickle cell disease are born in counties with , CDC researchers detailed in Morbidity and Mortality Weekly Report (MMWR).

Who can sue the FDA? Supreme Court Justice Samuel Alito's beyond only the current mifepristone case. (STAT)

Grieving? Watch your step -- and other capabilities could be impaired. (NPR)

The robot is in: are offering preventive medicine screenings and reminding older adults to take their medications. (New York Post)

"I could kill someone": , according to a report from the Government Accountability Office. (Washington Times)

Is it time to implement ? These scientists think so. (Science)

The Centers for Medicare & Medicaid Services did not ensure that selected states complied with Medicaid managed care mental health and substance use disorder parity requirements, said an .

Meanwhile, new federal rules aimed at ensuring continued health coverage for low-income children are with Florida. (Tampa Bay Times)

For , memories may not be visual. (CNN)

A survey from the found that nurses at all career levels desire more mentorship opportunities.

Syndromic panels that test for multiple causes of rash may measles in children recently vaccinated with the measles, mumps, and rubella vaccine. (MMWR)

The FDA for tenofovir alafenamide (Vemlidy) to treat chronic hepatitis B virus infection to include pediatric patients 6 years and older, drugmaker Gilead announced.

Meanwhile, Bristol Myers Squibb said a phase III trial of ozanimod (Zeposia) for moderate-to-severe active Crohn's disease .

And Amneal Pharmaceuticals is voluntarily recalling certain lots of vancomycin hydrochloride due to the potential for over-potent bottles that pose a risk to patients, the .

Self-proclaimed "mean old dog walker," Ron Louie, MD, said a dog helped . (JAMA Oncology)

Human milk has vast benefits for infants. Researchers are looking to for adults. (STAT)

Potentially the in the Americas to date has arrived, with Brazil, Argentina, and Paraguay being hardest hit. (Reuters)

  • author['full_name']

    Genevieve Friedman is the Perspectives Editor at 51˶. She is also a member of the content strategy team, co-producer of Anamnesis, and runs the interview series, “Medical Mavericks.”